Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;72(1):149-159.
doi: 10.1111/jgs.18632. Epub 2023 Oct 11.

Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study

Shannon Halloway  1 , Denis A Evans  2   3 , Pankaja Desai  2   3 , Klodian Dhana  2   3 , Todd Beck  2   3 , Kumar B Rajan  2   3   4
Affiliations

Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study

Shannon Halloway et al. J Am Geriatr Soc. 2024 Jan.

Abstract

Background: Total tau (t-tau), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) are neuronal cytoskeletal biomarkers that may indicate greater risk of poor outcomes in age-related conditions, including mortality. Health disparities experienced by some racial minority subgroups may influence biomarker expression and effects on longevity. We aimed to examine (a) associations of serum t-tau, NfL, and GFAP with overall and cardiovascular mortality and (b) differences in associations by racial background.

Methods: Data came from 1327 older participants from the Chicago Health and Aging Project (CHAP), a longitudinal population-based study. Cox proportional hazards regression models were used to examine associations between concentrations of serum t-tau, NfL, and GFAP biomarker(s) and mortality (overall/cardiovascular mortality based on age at death). Interaction terms were used to examine differences between African-American and European-American participants. Models were adjusted for age, sex, education, the APOE-ε4 allele, body mass index, chronic health conditions, and cognitive and physical functioning.

Results: Models showed that fivefold higher concentrations of t-tau (HR = 1.46, 95% CI: 1.27, 1.68), NfL (HR = 2.13, 95% CI: 1.76, 2.58), and GFAP (HR = 1.43, 95% CI: 1.08, 1.90) were separately associated with increased risk of overall mortality, with higher risk in African Americans in t-tau or NfL. In models with all biomarkers, NfL (HR = 2.17, 95% CI: 1.65, 2.85) was associated with risk of overall mortality, with racial differences in t-tau. Higher concentrations of t-tau (HR = 1.32, 95% CI: 1.02, 1.70), NfL (HR = 1.95, 95% CI: 1.40, 2.72), and GFAP (HR = 1.87, 95% CI: 1.18, 2.98) were separately associated with risk of cardiovascular mortality, with racial differences in t-tau, NfL, or GFAP. In combined models, NfL (HR = 1.73, 95% CI: 1.08, 2.78) was associated with cardiovascular mortality.

Conclusions: Serum t-tau, NfL, and GFAP may be early indicators for mortality outcomes among older adults, with racial differences among associations.

Keywords: biomarkers; blood; cardiovascular; longevity; mortality.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest.

Similar articles

See all similar articles

References

    1. Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, Trojanowski JQ. Total and phosphorylated tau protein as biological markers of Alzheimer’s disease. Exp Gerontol 2010;45(1):30. doi:10.1016/j.exger.2009.10.010 - DOI - PMC - PubMed
    1. Mielke MM, Syrjanen JA, Blennow K, et al. Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin. Alzheimer’s Dement 2019;15(11):1437–1447. doi:10.1016/j.jalz.2019.07.009 - DOI - PMC - PubMed
    1. Rajan KB, Aggarwal NT, McAninch EA, et al. Remote blood biomarkers of longitudinal cognitive outcomes in a population study. Ann Neurol 2020;88(6):1065–1076. doi:10.1002/ana.25874 - DOI - PMC - PubMed
    1. Pase MP, Himali JJ, Aparicio HJ, et al. Plasma total-tau as a biomarker of stroke risk in the community. Ann Neurol 2019;86(3):463–467. doi:10.1002/ana.25542 - DOI - PMC - PubMed
    1. Benedet AL, Ashton NJ, Pascoal TA, et al. Plasma neurofilament light associates with Alzheimer’s disease metabolic decline in amyloid-positive individuals. Alzheimers Dement (Amst) 2019;11(1):679–689. doi:10.1016/j.dadm.2019.08.002 - DOI - PMC - PubMed

Publication types

LinkOut - more resources